Kennedy Capital Management, Inc. Vanda Pharmaceuticals Inc. Transaction History
Kennedy Capital Management, Inc.
- $4.23 Billion
- Q4 2024
A detailed history of Kennedy Capital Management, Inc. transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Kennedy Capital Management, Inc. holds 221,321 shares of VNDA stock, worth $993,731. This represents 0.03% of its overall portfolio holdings.
Number of Shares
221,321
Previous 226,196
2.16%
Holding current value
$993,731
Previous $1.06 Million
-0.0%
% of portfolio
0.03%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding VNDA
# of Institutions
155Shares Held
43.7MCall Options Held
33.8KPut Options Held
28.7K-
Black Rock Inc. New York, NY8.14MShares$36.5 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.85MShares$17.3 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.51MShares$15.7 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.49MShares$11.2 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.35MShares$10.6 Million0.85% of portfolio
About Vanda Pharmaceuticals Inc.
- Ticker VNDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,561,500
- Market Cap $254M
- Description
- Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...